188 related articles for article (PubMed ID: 19806501)
1. Reovirus: Rationale and clinical trial update.
Lal R; Harris D; Postel-Vinay S; de Bono J
Curr Opin Mol Ther; 2009 Oct; 11(5):532-9. PubMed ID: 19806501
[TBL] [Abstract][Full Text] [Related]
2. Reovirus-based therapy for cancer.
Kelly K; Nawrocki S; Mita A; Coffey M; Giles FJ; Mita M
Expert Opin Biol Ther; 2009 Jul; 9(7):817-30. PubMed ID: 19527106
[TBL] [Abstract][Full Text] [Related]
3. Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.
Stoeckel J; Hay JG
Curr Opin Mol Ther; 2006 Jun; 8(3):249-60. PubMed ID: 16774045
[TBL] [Abstract][Full Text] [Related]
4. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic viral therapy using reovirus.
Thirukkumaran C; Morris DG
Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
[TBL] [Abstract][Full Text] [Related]
6. Reovirus therapy in cancer: has the orphan virus found a home?
Yap TA; Brunetto A; Pandha H; Harrington K; Debono JS
Expert Opin Investig Drugs; 2008 Dec; 17(12):1925-35. PubMed ID: 19012507
[TBL] [Abstract][Full Text] [Related]
7. Reovirus: viral therapy for cancer 'as nature intended'.
Comins C; Heinemann L; Harrington K; Melcher A; De Bono J; Pandha H
Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):548-54. PubMed ID: 18583112
[TBL] [Abstract][Full Text] [Related]
8. Reovirus - possible therapy of cancer.
Figova K; Hrabeta J; Eckschlager T
Neoplasma; 2006; 53(6):457-62. PubMed ID: 17167712
[TBL] [Abstract][Full Text] [Related]
9. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
Kapadia R; Coffey MC
Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic Viral Therapy Using Reovirus.
Thirukkumaran C; Morris DG
Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
[TBL] [Abstract][Full Text] [Related]
11. JX-594, a targeted oncolytic poxvirus for the treatment of cancer.
Merrick AE; Ilett EJ; Melcher AA
Curr Opin Investig Drugs; 2009 Dec; 10(12):1372-82. PubMed ID: 19943208
[TBL] [Abstract][Full Text] [Related]
12. Reovirus and tumor oncolysis.
Kim M; Chung YH; Johnston RN
J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
[TBL] [Abstract][Full Text] [Related]
13. Advances in oncolytic viral therapy.
Woo Y; Adusumilli PS; Fong Y
Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
[TBL] [Abstract][Full Text] [Related]
14. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer.
Vidal L; Pandha HS; Yap TA; White CL; Twigger K; Vile RG; Melcher A; Coffey M; Harrington KJ; DeBono JS
Clin Cancer Res; 2008 Nov; 14(21):7127-37. PubMed ID: 18981012
[TBL] [Abstract][Full Text] [Related]
15. Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.
Liu TC; Kirn D
Cancer Res; 2007 Jan; 67(2):429-32. PubMed ID: 17234747
[TBL] [Abstract][Full Text] [Related]
16. REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer.
Comins C; Spicer J; Protheroe A; Roulstone V; Twigger K; White CM; Vile R; Melcher A; Coffey MC; Mettinger KL; Nuovo G; Cohn DE; Phelps M; Harrington KJ; Pandha HS
Clin Cancer Res; 2010 Nov; 16(22):5564-72. PubMed ID: 20926400
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts.
Hingorani P; Zhang W; Lin J; Liu L; Guha C; Kolb EA
Cancer; 2011 Apr; 117(8):1764-74. PubMed ID: 21472724
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors.
Roulstone V; Khan K; Pandha HS; Rudman S; Coffey M; Gill GM; Melcher AA; Vile R; Harrington KJ; de Bono J; Spicer J
Clin Cancer Res; 2015 Mar; 21(6):1305-12. PubMed ID: 25424857
[TBL] [Abstract][Full Text] [Related]
19. Potentiating oncolytic viruses by targeted drug intervention.
Mahoney DJ; Stojdl DF
Curr Opin Mol Ther; 2010 Aug; 12(4):394-402. PubMed ID: 20677090
[TBL] [Abstract][Full Text] [Related]
20. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
Shmulevitz M; Lee PW
Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
